21. März 2022

Wittekind, Charlotte E. ORCID: 0000-0002-5841-0067; Takano, Keisuke; Sckopke, Philipp; Winkler, Markus H.; Werner, Gabriela G.; Ehring, Thomas; Rüther, Tobias (2022): Efficacy of approach bias modification as an add-on to smoking cessation treatment: study protocol for a randomized-controlled double-blind trial. Trials, 23: 223. ISSN 1745-6215

23. Februar 2023

Kühnisch, Jan; Zhao, Tianyu; Bertelsen, Randi J.; Jörres, Rudolf A.; Nowak, Dennis; Heinrich, Joachim (2023): The impact of gingivitis reduction on lung function: a randomized trial under intensified oral hygiene. Trials, 24 (1). ISSN 1745-6215

25. April 2023

Funk, Julia; Kopf-Beck, Johannes; Watkins, Edward; Ehring, Thomas (2023): Does an app designed to reduce repetitive negative thinking decrease depression and anxiety in young people? (RETHINK): a randomized controlled prevention trial. Trials, 24 (1). ISSN 1745-6215

17. Mai 2023

Degenhardt, Tom; Fasching, Peter A.; Lüftner, Diana; Müller, Volkmar; Thomssen, Christoph; Schem, Christian; Witzel, Isabell; Decker, Thomas; Tesch, Hans; Kümmel, Sherko; Uleer, Christoph; Wuerstlein, Rachel; Hoffmann, Oliver; Warm, Mathias; Marschner, Norbert; Schinköthe, Timo; Kates, Ronald E.; Schumacher, Johannes; Otremba, Burkhard; Zaiss, Matthias; Harbeck, Nadia; Schmidt, Marcus (2023): PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant. Trials, 24 (1). ISSN 1745-6215

6. Juni 2023

Dierig, A.; Hoelscher, M.; Schultz, S.; Hoffmann, L.; Jarchow-MacDonald, A.; Svensson, E. M.; Te Brake, L.; Aarnoutse, R.; Boeree, M.; McHugh, T. D.; Wildner, L. M.; Gong, X.; Phillips, P. P. J.; Minja, L. T.; Ntinginya, N.; Mpagama, S.; Liyoyo, A.; Wallis, R. S.; Sebe, M.; Mhimbira, F. A.; Mbeya, B.; Rassool, M.; Geiter, L.; Cho, Y. L.; Heinrich, N. (2023): A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxacin in adult subjects with newly diagnosed, uncomplicated, smear-positive, drug-sensitive pulmonary tuberculosis. Trials, 24 (1). ISSN 1745-6215